JGK-263 is an orally active Glycogen synthase kinase-3beta (GSK-3beta) inhibitor. JGK-263 exhibits neuroprotective effect and can improve motor function. JGK-263 can be used for the research of neurological disease, such as amyotrophic lateral sclerosis (ALS)[1].
Molecular Weight:
303.75
CAS Number:
[1408054-46-5]
Formula:
C14H14ClN5O
Target:
GSK-3
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
